![Bethany Sensenig](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bethany Sensenig
Director/Board Member at
SUPERNUS PHARMACEUTICALS, INC.
Net worth: 33 977 $ as of 2026-05-30
Profile
Bethany L.
Sensenig is currently an Independent Director at Supernus Pharmaceuticals, Inc. since 2023, an Independent Director at Alpha Cognition, Inc. starting in 2026, and Chief Executive & Financial Officer at Naia Rare Diseases LLC.
Former roles include Independent Director at KalVista Pharmaceuticals, Inc. from 2025 to 2026, Vice President-Finance & Commercial Operations at Biogen, Inc. from 2006 to 2019, Chief Financial Officer at Radius Health, Inc. from 2023 to 2026, Chief Executive & Financial Officer at 9 Meters Biopharma, Inc. in 2023, and Chief Financial Officer & Head-US Operations at Minovia Therapeutics Ltd. from 2019 to 2022.
Education includes undergraduate studies at Montreat College and an MBA from Western Carolina University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ALPHA COGNITION INC 0.03% | 2026-04-15 | 5,489 ( 0.03% ) | 33 977 $ | 2026-05-30 |
| 2026-04-28 | 0 ( -.--% ) | - $ | 2026-05-30 |
Bethany Sensenig active positions
| Companies | Position | Start |
|---|---|---|
| SUPERNUS PHARMACEUTICALS, INC. | Director/Board Member | 2023-08-20 |
| ALPHA COGNITION INC. | Director/Board Member | 2026-04-14 |
Naia Rare Diseases LLC
 Naia Rare Diseases LLC Medical/Nursing ServicesHealth Services Manufactures biopharmaceutical products | Chief Executive Officer | - |
Former positions of Bethany Sensenig
| Companies | Position | End |
|---|---|---|
| KALVISTA PHARMA | Director/Board Member | 2026-06-10 |
| RADIUS HEALTH, INC. | Director of Finance/CFO | 2026-03-31 |
| 9 METERS BIOPHARMA, INC. | Chief Executive Officer | 2023-07-16 |
Minovia Therapeutics Ltd.
 Minovia Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops mitochondrial cell therapies for clinical-stage biotechnology company | Director of Finance/CFO | 2021-12-31 |
| BIOGEN INC. | Corporate Officer/Principal | 2019-02-28 |
Training of Bethany Sensenig
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
73
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics | Health Technology |
Montreat College
 Montreat College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Western Carolina University
 Western Carolina University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Supernus Pharmaceuticals, Inc.
 Supernus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of central nervous system diseases | Health Technology |
KalVista Pharmaceuticals, Inc.
 KalVista Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets small molecule protease inhibitors for diseases | Health Technology |
9 Meters Biopharma, Inc.
 9 Meters Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals for people with rare digestive diseases and gastrointestinal conditions | Health Technology |
Minovia Therapeutics Ltd.
Minovia Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops mitochondrial cell therapies for clinical-stage biotechnology company | Health Technology |
Naia Rare Diseases LLC
Naia Rare Diseases LLC Medical/Nursing ServicesHealth Services Manufactures biopharmaceutical products | Health Services |
Alpha Cognition, Inc.
 Alpha Cognition, Inc. Financial ConglomeratesFinance Develops pharmaceutical products for treating neurodegenerative diseases | Finance |
- Stock Market
- Insiders
- Bethany Sensenig
